COVID-19 and hyperglycemia/diabetes

作     者：Konstantinos Michalakis Ioannis Ilias 

作者机构：Private PracticeAthens GR-11521Greece Department of EndocrinologyDiabetes and MetabolismElena Venizelou HospitalAthens GR-11521Greece 

出 版 物：《World Journal of Diabetes》 (世界糖尿病杂志（英文版）（电子版）)

年 卷 期：2021年第12卷第5期

页      面：642-650页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：COVID-19 Humans SARS-CoV-2 Risk factors Glucose Inflammation Diabetes 

摘      要：In early studies regarding coronavirus disease 2019(COVID-19),type 2 diabetes mellitus was considered to contribute substantially to the disease’s inflammatory ***,even hyperglycemia,regardless of insulin resistance or diabetes mellitus,was found to be additionally *** studies have shown inflammation of the pancreaticβcells in COVID-19,even leading to new onset diabetes *** hereby summarize core literature on glycemia and COVID-19,and present implicated pathways and mechanisms.